Craniopharyngeal Duct Tumor

Craniopharyngeal Duct Tumor

Article
Brain & Nerve
Eye & Vision
+4
Contributed byKrish Tangella MD, MBADec 01, 2020

The topic Craniopharyngeal Duct Tumor you are seeking is a synonym, or alternative name, or is closely related to the medical condition Craniopharyngioma.

Quick Summary:

  • A Craniopharyngioma (CP) is a type of brain tumor. A brain tumor may be described as a mass of abnormally growing cells arising from the brain tissue (brain parenchyma and meninges) or the spinal cord (central spine). The brain along-with the spinal cord constitute the central nervous system (CNS) of the body
  • Broadly, brain tumors are classified as benign (non-cancerous) and malignant. Malignant tumors are cancerous and can spread or metastasize to other regions of the body. They generally exhibit rapid growth and, in some cases, may present symptoms during the early stages of development
  • The World Health Organization (WHO) classifies central nervous system tumors according to their grade and histological subtypes. A tumor subtype is determined by a pathologist after examining a tissue biopsy of the tumor under the microscope. This WHO classification system is used by healthcare professionals all over the world in diagnosing and treating these tumors
  • Craniopharyngiomas are relatively benign and slow-growing tumors that arises from the sellar and suprasellar region, at the base of the brain. A large subset of the tumors are diagnosed in childhood, although adults are also known to be affected. Per WHO, Craniopharyngioma forms part of a group of tumors designated as “tumors of the sellar region”
  • The sellar region includes the sellar turcica and the pituitary gland. It is located just below the center of the brain and bounded by other vital structures such as the hypothalamus, optic nerve, internal carotid artery, and the brainstem. The pituitary gland is the “master gland” of the body that regulates all the other endocrine glands
  • There are two histological subtypes of Craniopharyngiomas:
    • Adamantinomatous Craniopharyngioma (adaCP): It is mostly observed in children and constitute between 86-89% of all Craniopharyngiomas
    • Papillary Craniopharyngioma (papCP): It is predominantly diagnosed in adults
  • A Craniopharyngioma is classified as a WHO grade I brain tumor, meaning that it is a low-grade tumor. Grade I tumors are the most benign of the tumors. They are slow-growing and are not known to infiltrate into the surrounding tissues. They offer a very high chance for surgery to be curative; and thus, have the best prognosis among all brain tumors with long-term survival being noted
  • The cause of formation of Craniopharyngioma is not well-established. It is believed that an abnormal development of the embryonic tissue during early pregnancy may be causative. In general, brain tumors may form from a combination of several factors including genetic, environmental, and lifestyle-related. The risk factors may include the presence of certain genetic disorders, exposure to ionized radiation, viral infections, and head trauma
  • Apart from headaches, seizures, muscle weakness, and dizziness, the signs and symptoms of Craniopharyngioma are typically associated with hormonal deficiencies in the body. Often, the tumor causes an obstruction of cerebrospinal fluid flow leading to hydrocephalus. The tumor is also associated with vision defects and neurological abnormalities including memory loss and personality changes. Severe complications may develop during/from treatment too
  • The treatments for Craniopharyngioma is usually challenging but may primarily involve surgery and/or radiation therapy. Hormonal therapy is an important component of treatment, depending on the specific combination of signs and symptoms noted for each individual. Sometimes, removing the tumor can worsen the signs and symptoms in some individuals
  • The prognosis depends on a wide variety of factors, including the size and histological type of the tumor, and overall health status of the individual. In a majority, the long-term prognosis of Craniopharyngioma may be unpredictable; however, continued vigilance, medical screening, and follow-up treatments are mandatory for prolonged periods. The outcomes also depend on the histological subtype of the tumor. Papillary subtypes have better prognosis when compared to the adamantinomatous subtypes

Please find comprehensive information on Craniopharyngioma regarding definition, distribution, risk factors, causes, signs & symptoms, diagnosis, complications, treatment, prevention, prognosis, and additional useful information HERE.

Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!